SSII — SS Innovations International, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1676163 ·
India
Last close
$1.33
Market Cap
$266.51M
52W High
$6.79
52W Low
$1.12
ADV30
109,633
Next earnings
2026-11-17
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 6,331,061 | 3,108,002 | -6,056,420 | -5,749,389 | 96,507,411 | 8,113,767 | 46,566,800 |
| Jun 2026 | 13,939,709 | 7,100,950 | -2,271,354 | -2,661,350 | 96,982,013 | 13,647,430 | 43,580,790 |
| Mar 2026 | 11,101,366 | 5,327,221 | -3,638,757 | -3,582,571 | 90,546,889 | 15,979,714 | 36,023,476 |
| Dec 2025 | 14,534,483 | 6,377,053 | -734,997 | -2,471,379 | 74,226,217 | 3,206,406 | 36,007,966 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-15,533,733
Investing CF
$-2,684,666
Financing CF
$26,101,145
CapEx
$-2,684,666
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.06
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-62,033,855
Inventory
$18,481,603
Receivables
$24,313,965
ST Investments
—
EBIT TTM
$-7,023,181
Pretax Income TTM
$-8,163,925
Interest Exp TTM
$1,140,744
Analysts
1
Yahoo Snapshot (yfinance, live)
Total Revenue
$52,404,908
EBITDA
$-7,190,425
Free Cash Flow
$-3,900,197
Enterprise Value
$667,500,864
Total Cash
$13,647,430
Total Debt
$17,872,490
Shares Out
200,385,435
Trailing EPS
$-0.06
Book Value
$0.27
ROE
-26.1%
ROA
-6.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 42,484,747 | -8,194,034 | -12,127,387 | 74,226,217 | 36,007,966 | 38,218,251 | -18,542,987 |
| Dec 2024 | 20,649,528 | -18,975,962 | -19,151,197 | 42,385,213 | 28,928,110 | 13,457,103 | -9,503,030 |
| Dec 2023 | 5,875,314 | -20,273,984 | -20,878,292 | 31,515,994 | 11,797,916 | 19,718,078 | -15,361,645 |
| Dec 2022 | 1,436,147 | -2,958,592 | -3,213,882 | 6,980,533 | 9,659,070 | -2,678,537 | -5,994,475 |
TTM Snapshot
Revenues TTM
$52,404,907
NetIncome TTM
$-12,433,264
OpCashFlow TTM
—
Assets (Latest)
$96,982,013
Forward EPS
$-0.06
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| OFIX | Orthofix Medical Inc. | $271.87M | $6.67 | — |
| PROF | Profound Medical Corp. | $259.32M | $7.08 | — |
| CLPT | ClearPoint Neuro, Inc. | $251.95M | $7.86 | — |
| NPCE | NeuroPace Inc | $282.50M | $8.20 | — |
| ZJYL | Jin Medical International Ltd. | $248.61M | $3.38 | — |
News headlines (Yahoo Finance, 1h cache)
SS Innovations International (SSII) Promotes Vishwa Srivastava to President, Appoints Gary Lo CFO
2026-11-13 20:30 · Yahoo
SS Innovations Strengthens Management Team in Preparation for Global Sales Expansion
2026-11-13 13:30 · Yahoo
SS Innovations International (SSII) CEO Outlines Growth Strategy as SSi Mantra Expands Robotic Surgery, Telesurgery, and Global Reach
2026-11-06 20:30 · Yahoo
SS Innovations International (SSII) Demonstrates Long-Distance Robotic Cardiac Surgery at Industry Events
2026-11-02 20:00 · Yahoo
SS Innovations International (SSII) Showcases Robotic Telesurgery Capabilities at International Medical Conferences
2026-10-26 19:30 · Yahoo
SS Innovations Showcases SSi Mantra Telesurgery Capabilities at October 2026 Conferences
2026-10-26 12:30 · Yahoo
SSi Falls 32% in Three Months: Should You Buy the Dip or Wait?
2026-10-23 16:45 · Yahoo
SS Innovations International (SSII) Submits FDA Response for SSi Mantra Surgical Robotic System
2026-10-14 18:30 · Yahoo
SS Innovations Submits Response to FDA Request for Additional Information Regarding the Company’s 510(k) Submission for the SSi Mantra
2026-10-13 12:30 · Yahoo
Zacks Initiates Coverage of SSi With Neutral Recommendation
2026-10-09 17:03 · Yahoo
Recent Insider Activity
| Filed | Trade | Insider | Title | Type | Price | Qty | Value |
|---|---|---|---|---|---|---|---|
| 2026-11-17 16:10:11 | 2026-11-17 | Sudhir Srivastava | COB, CEO, 10% | P - Purchase | 3 | 100000 | 300000 |